MiMedx Group, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
MiMedx Group, Inc. (MDXG) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $1.45 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2012-11-13
- MiMedx Group, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2012-09-30 was $1.79M, a 590.74% increase year-over-year.
- MiMedx Group, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2012-06-30 was $14.08K.
- MiMedx Group, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2012-03-31 was -$352.72K, a 154.95% decline year-over-year.
- MiMedx Group, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2011-12-31 was $423.24K.
- MiMedx Group, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2011 was $1.26M, a 473.80% increase from fiscal 2010.
- MiMedx Group, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2010 was $218.94K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2012-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $1.80M derived: sum of 2 quarters · filed 2012-11-13 | $1.45M 10-Q · filed 2012-11-13 | $1.87M derived: sum of 4 quarters · filed 2012-11-13 |
| 2012-06-30 | $14.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$338.64K 10-Q · filed 2012-08-14 | $84.60K derived: sum of 3 quarters · filed 2012-08-14 | $343.09K derived: sum of 4 quarters · filed 2012-11-13 |
| 2012-03-31 | -$352.72K 10-Q · filed 2012-05-14 | $70.52K derived: sum of 2 quarters · filed 2012-05-14 | $329.01K derived: sum of 3 quarters · filed 2012-11-13 | $261.65K derived: sum of 4 quarters · filed 2012-11-13 |
| 2011-12-31 | $423.24K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $681.73K derived: sum of 2 quarters · filed 2012-11-13 | $614.37K derived: sum of 3 quarters · filed 2012-11-13 | $1.26M 10-K · filed 2012-03-29 |
| 2011-09-30 | $258.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $191.13K derived: sum of 2 quarters · filed 2012-11-13 | $833.01K 10-Q · filed 2012-11-13 | $442.67K derived: sum of 4 quarters · filed 2012-11-13 |
| 2011-06-30 | -$67.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $574.52K 10-Q · filed 2012-08-14 | $184.18K derived: sum of 3 quarters · filed 2012-08-14 | $66.54K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $641.88K 10-Q · filed 2012-05-14 | $251.54K derived: sum of 2 quarters · filed 2012-05-14 | $133.90K derived: sum of 3 quarters · filed 2012-05-14 | |
| 2010-12-31 | -$390.34K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | -$507.98K derived: sum of 2 quarters · filed 2012-03-29 | $218.94K 10-K · filed 2012-03-29 | |
| 2010-09-30 | -$117.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $609.28K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $726.92K 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |